Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Smoldering Multiple Myeloma × Lenalidomide × Clear all

Phase

Phase 2 7 Phase 1 3 Phase 3 2 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Smoldering Multiple Myeloma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1

Interventions

pembrolizumab 1 Lenalidomide 1 Leflunomide 1 Immunotherapy, Active 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03631043 2025-12-19

Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed

Smoldering Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡